Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 14, 2013

Undetected creatinine levels

Yu Chen and Heather Tarr

Corresponding author: Yu Chen, MD, PhD, DABCC, FACB, FCACB, Division of Clinical Biochemistry, Department of Laboratory Medicine, Dr. Everett Chalmers Regional Hospital, Horizon Health Network, Fredericton, New Brunswick, Canada E3B 5N5, Phone: +1 506 4525443, Fax: +1 506 4525422, E-mail:

References

1. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501–6.10.1007/BF00558131Search in Google Scholar

2.Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180–4.10.1056/NEJM200007203430304Search in Google Scholar

3. Lognard M, Cavalier E, Chapelle JP, Lambermont B, Krzesinski JM, Delanaye P. Acetylcysteine and enzymatic creatinine: beware of laboratory artefact! Intensive Care Med 2008;34:973–4.10.1007/s00134-007-0972-9Search in Google Scholar

4. Daly TM, Kempe KC, Scott MG. “Bouncing” creatinine levels. N Engl J Med 1996;334:1749–50.10.1056/NEJM199606273342617Search in Google Scholar

Received: 2013-9-26
Accepted: 2013-10-20
Published Online: 2013-11-14
Published in Print: 2014-04-01

©2014 by Walter de Gruyter Berlin/Boston